scholarly article | Q13442814 |
P50 | author | Bronwyn J Barkla | Q57067750 |
P2093 | author name string | Yvonne Rosenstein | |
Gustavo Pedraza-Alva | |||
Rosario Vera-Estrella | |||
Angel Flores-Alcantar | |||
Jose Pablo Ocelotl-Oviedo | |||
Cecilia Martínez-Campos | |||
Maria Elena Bravo-Adame | |||
P2860 | cites work | Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD | Q24291213 |
Pharmacological Inhibition of BMK1 Suppresses Tumor Growth through Promyelocytic Leukemia Protein | Q24299360 | ||
Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome | Q24303591 | ||
Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1 | Q24304533 | ||
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription | Q24306379 | ||
Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155 | Q24532078 | ||
Molecular mechanisms of T cell co-stimulation and co-inhibition | Q26864888 | ||
MEK5/ERK5 pathway: the first fifteen years | Q26866383 | ||
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells | Q27860599 | ||
CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes | Q28141639 | ||
MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway | Q28143630 | ||
Transcriptional regulation by the phosphorylation-dependent factor CREB | Q28210623 | ||
The role of PML in tumor suppression | Q28217779 | ||
T cell activation through the CD43 molecule leads to Vav tyrosine phosphorylation and mitogen-activated protein kinase pathway activation | Q28272069 | ||
Leukosialin, a major sialoglycoprotein on human leukocytes as differentiation antigens | Q28285332 | ||
CREB is a regulatory target for the protein kinase Akt/PKB | Q28289946 | ||
Negative regulation of T-cell adhesion and activation by CD43 | Q28508953 | ||
Hydrogen peroxide stimulates c-Src-mediated big mitogen-activated protein kinase 1 (BMK1) and the MEF2C signaling pathway in PC12 cells: potential role in cell survival following oxidative insults | Q28583500 | ||
Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor | Q28584997 | ||
CD43 is a murine T cell costimulatory receptor that functions independently of CD28 | Q28586182 | ||
CD43-specific activation of T cells induces association of CD43 to Fyn kinase | Q30176770 | ||
The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism | Q33726100 | ||
Anergic T cells are metabolically anergic | Q33908515 | ||
Inflammatory cytokines as a third signal for T cell activation | Q33936084 | ||
The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation | Q34242691 | ||
The CD28 signaling pathway regulates glucose metabolism | Q34525357 | ||
Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. | Q34545142 | ||
Negative regulation of T cell homing by CD43 | Q74405453 | ||
CD43 modulates severity and onset of experimental autoimmune encephalomyelitis | Q79353937 | ||
Comparative analysis of T-cell costimulation and CD43 activation reveals novel signaling pathways and target genes | Q80388686 | ||
TCR-dependent cell response is modulated by the timing of CD43 engagement | Q83918137 | ||
Day/night regulation of aquaporins during the CAM cycle in Mesembryanthemum crystallinum | Q84898722 | ||
CD43 interaction with ezrin-radixin-moesin (ERM) proteins regulates T-cell trafficking and CD43 phosphorylation | Q34749263 | ||
CD43 promotes cells transformation by preventing merlin-mediated contact inhibition of growth | Q35049278 | ||
Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression | Q35097484 | ||
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation | Q35607137 | ||
Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase | Q35822985 | ||
Signaling through CD43 regulates CD4 T-cell trafficking | Q36059627 | ||
Fuel feeds function: energy metabolism and the T-cell response | Q36292868 | ||
Emerging roles of PKM2 in cell metabolism and cancer progression | Q36303571 | ||
Regulation of cellular functions by the ERK5 signalling pathway | Q36352695 | ||
Association of the src gene product of Rous sarcoma virus with cytoskeletal structures of chicken embryo fibroblasts | Q36393988 | ||
The life of a cell: apoptosis regulation by the PI3K/PKB pathway | Q37289433 | ||
STAT3 in CD4+ T helper cell differentiation and inflammatory diseases | Q37323270 | ||
Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy | Q37459543 | ||
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells | Q37692621 | ||
Fluorescent cell barcoding for multiplex flow cytometry | Q37826155 | ||
Dual roles of PKM2 in cancer metabolism | Q38065057 | ||
Stat3 upregulates MEK5 expression in human breast cancer cells | Q38336447 | ||
Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy | Q38624477 | ||
CD43 in the nucleus and cytoplasm of lung cancer is a potential therapeutic target | Q39270793 | ||
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth | Q39773538 | ||
Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells | Q40048868 | ||
PKCtheta is required for the activation of human T lymphocytes induced by CD43 engagement. | Q40496813 | ||
CD43 has a functional NLS, interacts with beta-catenin, and affects gene expression | Q40581910 | ||
Overexpression of leukocyte marker CD43 causes activation of the tumor suppressor proteins p53 and ARF. | Q40607190 | ||
CD43 expression in a B cell lymphoma, WEHI 231, reduces susceptibility to G1 arrest and extends survival in culture upon serum depletion | Q41154331 | ||
MEM-59 monoclonal antibody detects a CD43 epitope involved in lymphocyte activation | Q41357001 | ||
The functional paradox of CD43 in leukocyte recruitment: a study using CD43-deficient mice. | Q41841334 | ||
Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element | Q42461521 | ||
CD43 regulates the threshold for T cell activation by targeting Cbl functions | Q42552884 | ||
TCR ligand discrimination is enforced by competing ERK positive and SHP-1 negative feedback pathways | Q44308973 | ||
The CD43 coreceptor molecule recruits the zeta-chain as part of its signaling pathway | Q44539447 | ||
T cell aggregation induced through CD43: intracellular signals and inhibition by the immunomodulatory drug leflunomide. | Q44583950 | ||
Dynamic regulation of T cell immunity by CD43. | Q48585438 | ||
Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies | Q48763190 | ||
CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis. | Q50585140 | ||
c-Maf expression in angioimmunoblastic T-cell lymphoma. | Q53512639 | ||
Expression and function of CD4 in a murine T-cell hybridoma | Q58974630 | ||
Expression of a new set of glycolytic isozymes in activated human peripheral lymphocytes | Q68477697 | ||
Expression on blood cells of sialophorin, the surface glycoprotein that is defective in Wiskott-Aldrich syndrome | Q68995955 | ||
Mechanism of mononuclear cell activation by an anti-CD43 (sialophorin) agonistic antibody | Q69349284 | ||
Isolation and characterization of leukosialin, a major sialoglycoprotein on human leukocytes | Q70010204 | ||
CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes | Q71929821 | ||
P433 | issue | 1 | |
P304 | page(s) | 87-99 | |
P577 | publication date | 2016-10-12 | |
P1433 | published in | Immunology | Q15754984 |
P1476 | title | An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes | |
P478 | volume | 150 |
Q40064195 | FOCIS goes south: advances in translational and clinical immunology |
Q54111949 | PKM2-dependent metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis. |
Q92649728 | Pyruvate Kinase M2: a Metabolic Bug in Re-Wiring the Tumor Microenvironment |
Search more.